| No. |
Company Name |
Business Description |
Partnering Objective |
| 1 |
Argenes
(Japan) |
Developing novel antibody therapeutic agent for rheumatoid arthritis (RA) |
Partnering with US/EU/Asian pharmaceuticals and biotech interested in the development and marketing of ARG098 and ARG171 in their territories. |
| 2 |
Arriva
(USA) |
Biopharmaceutical company focused on developing anti-inflammatory therapies for treating respiratory diseases with global markets. |
| (1) |
Looking for co-development partners or equity investment. |
| (2) |
Seeking funding to complete development of rAAT. |
|
| 3 |
Ascenta
(USA) |
Discovering and developing new medicines to stop cancer. technology consists of agents designed to re-establish the natural program of apoptosis that shuts down cell growth and proliferation in abnormal cells |
Partners for potential Phase 3 trials of the lead drug candidate, and/or for IND stage pipeline drug candidates |
| 4 |
BIOTECTID GmbH
(Germany) |
Developing non-invasive, direct, rapid and high-resolution spatial imaging diagnostics of tiny sources of chronic inflammation in rheumatoid arthritis. |
| (1) |
Manufacturing small charges of biopharmaceuticals on the basis of its German production permission and its certificate of GMP Compliance. |
| (2) |
Looking for a partner focused on the development of novel molecular diagnostics for chronic inflammation on the basis of laboratory tests. |
|
| 5 |
Epitomics, Inc.
(USA) |
Novel antibody technologies for development of "best in class" antibody therapeutics |
Seeking investments to advance novel antibody drug leads; seek partners to co-develop novel antibody drug leads. |
| 6 |
Exactech Taiwan
(Taiwan) |
Fast growing orthopaedic implant company |
Fast growing orthopaedic implant company To facilitate the development of medical products by leveraging high quality technical skills and resources available |
| 7 |
Genelabs
(USA) |
A biopharmaceutical company engaged in the discovery and development of infectious disease therapies focused on HCV |
Searching for in-license or collaboration opportunities in the area of infectious diseases, antivirals, antibiotics and antifungals. Current internal research programs are focused in small molecule hepatitis C. Biologics, botanicals, antibodies will not be a good fit for Genelabs. |
| 8 |
Mimotopes
(Australia) |
An epitope mapping, peptide and discovery chemistry company that develops, markets and distributes products and services for the life-science sector |
Seeking customers and collaborators who seek more than just a passive peptide manufacturer, but require an interactive chemistry partner who suggests useful strategies to produce and optimise peptides, from discovery to clinical development. |
| 9 |
MagQu Co., Ltd.
(Taiwan) |
The core technologies is so-called ImmunoMagnetic Reduction (IMR) bio-assay. IMR involves bio-functionalized magnetic nanoparticles and immunomagnetic analyzer. |
Searching for global collaborations in IMR applications, business development, and co-developing assay kits. |
| 10 |
Medigen
(Taiwan) |
Developing new drugs/technologies for liver diseases and cancers of Asian significance, as well as for nucleic acid testing for immune related diseases (HLA) and infectious disease (HBV/HCV/HIV). |
New Drug Development: Acquiring regional rights for all indications under strategic alliance.
Nucleic Acid Testing for Clinical Diagnostics: Seeking innovative nucleic acid testing based companies for partnership and planning to pursue further M&A activities to more quickly grow our product portfolio and market share. |
| 11 |
Nanotechnology Victoria Ltd
(Australia) |
Therapeutic delivery technologies;Superior contrast reagents for targeted in vivo imaging applications; BeadNanoArray Biochip applications. |
Looking for manufacturing capacity, expertise and facilities which can produce surfaces and materials at the micro and nanoscale for biomedical applications. |
| 12 |
Pacific Healthcare Co., Ltd.
(Thailand) |
Pharmaceuticals, medical supplies & equipment and consumer health products |
Looking forward to potential partners who want to grow in Southeast Asia in form of market expansion. |
| 13 |
PharmEng International Inc.
(Canada) |
Offering a broad range of services include: cGMP Compliance, Regulatory Affairs and Validation Services, Master Plan and Engineering, Product Development, Training and Contract Manufacturing |
Looking for Asian partners to better serve Asian pharmaceutical and biotechnology industries. |
| 14 |
SanBio, Inc.
(USA) |
Developing regenerative therapies for CNS disorders using cells derived from bone marrow |
Seeking potential corporate partners for our lead product SB623 for CNS disorders including stroke, Parkinson' s diseases and spinal cord injury and potential investors for equity financing. |
| 15 |
SIRO Clinpharm
(India) |
Offering full spectrum services of Phase I- IV Clinical Trials to Pharmaceutical, Biotech & healthcare industry. |
Looking forward to partnering with local or South Asian pharmaceutical, biotech companies or contract research organizations. |
| 16 |
SofSera Corporation
(Japan) |
Using HAp nano technology to develop medical device that provides anti infection feature |
Look for any possible collaboration. |
| 17 |
Stryker International
(Singapore) |
Developing products from orthopaedic implants to medical beds and stretchers, minimally invasive surgical devices and other or equipment across specialties |
Interested in innovations and new capabilities in different specialties in general. |
| 18 |
Suntec Medical, Inc.
(USA) |
Developing proprietary biomarkers for personalize medicine and Super-generic drug |
Seeking partners, collaborators, and financial supporters to
| (1) |
expand manufacturing facility to meet FDA CGMP requirement |
| (2) |
Clinical trial |
| (3) |
develop additional super-generic drugs. |
|
| 19 |
SunTen Phytotech Co., Ltd
(Taiwan) |
Developing novel pharmaceutical and nutraceutical products from botanical sources. |
Seeking business alliances for global pharmaceutical and nutraceutical product development as well as for marketing. |
| 20 |
Vaxiva Biosciences K.K.
(Japan) |
Development of new vaccine products for prevention of seasonal influenza, hepatitis B, Japanese encephalitis, and other infectious diseases |
Interested in connecting with:
| (1) |
Potential licensors with novel vaccine technologies or antigens that have commercialization potential alone |
| (2) |
Established vaccine manufacturers who are looking for technologies to develop improved products |
| (3) |
Potential investors who recognize the promising nature of the global vaccine sector |
|
¡@
